DE3733540A1 - Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes - Google Patents

Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes

Info

Publication number
DE3733540A1
DE3733540A1 DE19873733540 DE3733540A DE3733540A1 DE 3733540 A1 DE3733540 A1 DE 3733540A1 DE 19873733540 DE19873733540 DE 19873733540 DE 3733540 A DE3733540 A DE 3733540A DE 3733540 A1 DE3733540 A1 DE 3733540A1
Authority
DE
Germany
Prior art keywords
composition according
weight
cellulose
microcrystalline cellulose
hydroxypropylmethyl cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19873733540
Other languages
German (de)
English (en)
Inventor
Henry C Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of DE3733540A1 publication Critical patent/DE3733540A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19873733540 1986-10-09 1987-10-03 Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes Withdrawn DE3733540A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE3733540A1 true DE3733540A1 (de) 1988-04-14

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19873733540 Withdrawn DE3733540A1 (de) 1986-10-09 1987-10-03 Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes

Country Status (24)

Country Link
JP (1) JPS63101334A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880004801A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU7942087A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1000732A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1332809C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH675831A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3733540A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK527487A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2014518A6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI874414L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2604902B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB8624213D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR871550B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU201875B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL84104A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1221493B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU87009A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8702294A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO874200L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ222083A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH24227A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT85880B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8703889L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA877617B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895780A1 (en) * 1997-07-31 1999-02-10 L. Perrigo Company Extended release tablets particularly containing pseudoephedrine hydrochloride
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05022B1 (et) * 1999-03-31 2008-06-16 Janssen Pharmaceutica N.V. Eelthelatineeritud tärklise kasutamine hüdrofiilses kontrollitud vabanemisega preparaadis ja hüdrofiilne kontrollitud vabanemisega preparaat
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
US7820200B2 (en) * 2004-09-09 2010-10-26 Luis Estrada Flores Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
EP0895780A1 (en) * 1997-07-31 1999-02-10 L. Perrigo Company Extended release tablets particularly containing pseudoephedrine hydrochloride

Also Published As

Publication number Publication date
ZA877617B (en) 1989-05-30
GR871550B (en) 1988-02-15
PT85880B (pt) 1990-07-31
CA1332809C (en) 1994-11-01
FI874414A7 (fi) 1988-04-10
FI874414L (fi) 1988-04-10
GB2195893A (en) 1988-04-20
NO874200L (no) 1988-04-11
FI874414A0 (fi) 1987-10-07
GB2195893B (en) 1991-05-08
SE8703889L (sv) 1988-04-10
NZ222083A (en) 1991-05-28
IT8748469A0 (it) 1987-10-08
DK527487D0 (da) 1987-10-08
KR880004801A (ko) 1988-06-27
ES2014518A6 (es) 1990-07-16
FR2604902B1 (fr) 1991-04-26
CH675831A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-11-15
BE1000732A5 (fr) 1989-03-21
GB8723515D0 (en) 1987-11-11
AU7942087A (en) 1988-04-14
NL8702294A (nl) 1988-05-02
GB8624213D0 (en) 1986-11-12
IL84104A0 (en) 1988-03-31
HU201875B (en) 1991-01-28
NO874200D0 (no) 1987-10-07
SE8703889D0 (sv) 1987-10-08
PH24227A (en) 1990-05-04
PT85880A (en) 1987-11-01
IT1221493B (it) 1990-07-06
DK527487A (da) 1988-04-10
HUT52958A (en) 1990-09-28
LU87009A1 (fr) 1988-05-03
JPS63101334A (ja) 1988-05-06
FR2604902A1 (fr) 1988-04-15

Similar Documents

Publication Publication Date Title
DE69004708T2 (de) Tablette mit Doppelwirkung.
DE3887179T2 (de) Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
DE68916983T2 (de) Verfahren zur Herstellung eines pharmazeutischen Granulats.
DE69832108T2 (de) Fenofibrathaltige Arzneizusammensetzung mit erhöhter Bioverfügbarkeit und Verfahren zu deren Herstellung
DE69730314T2 (de) Dosierungsform von ibuprofen
DE69431247T2 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE69623634T2 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
DE60020501T3 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE19529862A1 (de) Pharmazeutische, oral anwendbare Zubereitung
DE69518237T2 (de) Feste pharmazeutische zubereitung mit (s)-2-(4-isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff
DE2323686A1 (de) Arzneimittelzubereitungsform mit langzeitwirkung und verfahren zu ihrer herstellung
LU84962A1 (de) Naproxen-und naproxen-natrium-tabletten mit kontrollierter wirkstoffreigabe
EP2477660A1 (de) Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin
DE60225686T2 (de) Paracetamol enthaltende tablette
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
DE3733540A1 (de) Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes
DE1907546A1 (de) Schnell zerfallende feste Dosierungseinheiten
DE69428455T3 (de) Verfahren zur herstellung von niedrigdosierten arzneimitteln
DE60103276T2 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
DE60111503T2 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
DE3226178A1 (de) Mittel enthaltend n-acetyl-p-aminophenol und ein antacidum

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee